NASDAQ:CRVS | Cash Flow Statement | Corvus Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$17.96M
2026-03-31-$13.69M$29,000.00-$10.37M$91,000.00-$144.85M$190.75M
2025-12-31-$12.32M$26,000.00-$9.19M$25,000.00$10.88M$20,000.00
2025-09-30-$10.16M
2025-06-30-$8M
2025-03-31$15.19M$22,000.00-$8.26M$36,000.00$4.24M$279,000.00
2024-12-31-$12.11M$20,000.00-$8.47M-$6.08M$18.61M
2024-09-30-$40.22M
2024-06-30-$4.26M
2024-03-31-$5.7M$23,000.00-$5.16M-$7,000.00
2023-12-31-$6.65M$28,000.00-$5.17M$0.00-$2.32M$0.00
2023-09-30-$6M
2023-06-30-$6.5M
2023-03-31-$7.87M$57,000.00-$8.11M$34,000.00$4.6M$4,000.00
2022-12-31-$9.82M$94,000.00-$7.55M$0.00-$3.88M
2022-09-30-$14.83M
2022-06-30-$8.36M
2022-03-31-$8.3M$87,000.00-$6.42M-$25.57M
2021-12-31-$9.24M$93,000.00-$6.86M-$2M$18,000.00
2021-09-30-$10.67M
2021-06-30-$11.75M
2021-03-31-$11.58M$137,000.00-$8.79M$4.85M$32.59M
2020-12-31$27.35M$142,000.00-$8.21M$0.00$463,000.00$1.22M
2020-09-30-$9.8M
2020-06-30-$10.61M
2020-03-31-$12.94M$184,000.00-$9.35M$27.7M
2019-12-31-$11.05M$185,000.00-$8.51M$5,000.00$4.6M$2,000.00
2019-09-30-$11M
2019-06-30-$12.98M
2019-03-31-$11.64M$186,000.00-$8.99M$16,000.00$8.77M$1,000.00
2018-12-31-$10.51M$180,000.00-$8.26M$135,000.00$6.53M$172,000.00
2018-09-30-$10.5M
2018-06-30-$11.63M
2018-03-31-$14.3M$219,000.00-$11.05M$6,000.00$3.62M$64.88M
2017-12-31-$11.93M$219,000.00-$10.98M-$8,000.00$10.67M$1.31M
2017-09-30-$12.72M
2017-06-30-$14.98M
2017-03-31-$16.04M$204,000.00-$12.75M$111,000.00$18.18M$8,000.00
2016-12-31-$11.09M-$9.41M$613,000.00$8.88M$3,000.00
2016-09-30-$10.3M
2016-06-30-$8.65M
2016-03-31-$6.35M-$5.64M$614,000.00
2015-12-31-$6.04M-$3.94M$864,000.00
2015-09-30-$3.15M
2015-06-30-$20.23M
2015-03-31-$1.91M-$2.32M$324,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$15.28M$105,000.00-$32.8M$174,000.00-$7.8M$36.43M
2024-12-31-$62.29M$85,000.00-$25.42M-$27.48M$49.03M
2023-12-31-$27.03M$151,000.00-$23.94M$34,000.00$15.54M$7.86M
2022-12-31-$41.31M$367,000.00-$27.02M$269,000.00-$23.28M$0.00
2021-12-31-$43.24M$460,000.00-$36.72M$5,000.00$21.56M$62.16M
2020-12-31-$6M$632,000.00-$34.78M$76,000.00$44.77M$1.31M
2019-12-31-$46.67M$743,000.00-$37.32M$25,000.00$3.26M$24,000.00
2018-12-31-$46.94M$847,000.00-$40.99M$355,000.00-$30.19M$65.27M
2017-12-31-$55.66M$842,000.00-$46.21M$266,000.00$84.83M$1.44M
2016-12-31-$36.38M$594,000.00-$27.86M$2.2M-$42.56M$71.36M
2015-12-31-$31.34M$148,000.00-$11.33M$1.75M-$92.03M$94.95M
2014-12-31-$161,000.00-$96,000.00